Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Rachel Heuer"'
Autor:
Traci Kruer, Naseema Gangat, Darci Zblewski, Moritz Binder, Ayalew Tefferi, Rami S. Komrokji, Aref Al-Kali, Hannah Newman, Mrinal M. Patnaik, Cameron Durrant, Abhishek A. Mangaonkar, David A. Sallman, Christopher Letson, Eric Padron, Alan F. List, Maria E. Balasis, Ted Shih, Rachel Heuer, Jeffery Hirvela, Adrian Lo
Publikováno v:
Blood
In this phase 1 trial, inhibition of granulocyte-macrophage colony-stimulating factor (GM-CSF) was associated with clinically meaningful responses in 5 of 15 patients with relapsed or refractory chronic myelomonocytic leukemia (CMML). Preliminary dat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40ac9dae8cdc999bbf122a368a3a4e8d
https://pubmed.ncbi.nlm.nih.gov/32294158
https://pubmed.ncbi.nlm.nih.gov/32294158
Autor:
Abhishek A. Mangaonkar, Aref Al-Kali, Jeffery Hirvela, Adrian Lo, Rami S. Komrokji, Eric Padron, Darci Zblewski, Deanna Kanne, Mrinal M. Patnaik, Rachel Heuer, Dale Chappell, Alan F. List, David A. Sallman, Cameron Durrant, Omar J. Ahmed, Maria E. Balasis, Rahil Ismail
Publikováno v:
Blood. 134:4234-4234
BACKGROUND: CMML is a myelodysplastic/myeloproliferative neoplasm with a median survival of 32 months and no therapies that improve its natural history. We have previously demonstrated that CMML bone marrow mononuclear cells (BMNCs) are hypersensitiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fd6045d43dd6f01913fa6c78e3529189
https://doi.org/10.1182/blood-2019-131181
https://doi.org/10.1182/blood-2019-131181